Kyntra Bio, Inc. (KYNB)

Kyntra Bio, Inc. (KYNB) is a healthcare company (biotechnology) based in the United States. The share price is $2.04, down 36.25% on the day, which values the company at $8.26M. Price as of 18 Nov 2026, 08:29 UTC, from Yahoo Finance.

Key facts

Share price
$2.04−36.25% today
Market value
$8.26M
Funk Score
9/100
200-week average
$67.8697% below
Sector
Healthcare

Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

Kyntra Bio, Inc. in more detail

KYNB trades at -0.3× next year's expected earnings, 1.8× sales. It sits 97% below its 200-week average of $67.86.

Over the last five fiscal years Kyntra Bio, Inc. has compounded revenue -48.4% a year. Its Funk Score is 9 out of 100 (financial strength 1.7, profitability 0.3, growth 0.7, each out of 10).

Worth checking: Altman Z in the distress zone; Share count keeps rising.

Kyntra Bio, Inc. (KYNB): questions and answers

What is Kyntra Bio, Inc.'s market cap?

Kyntra Bio, Inc. is valued at $8.26M at a share price of $2.04.

Is KYNB above its 200-week moving average?

No. KYNB is 97.0% below its 200-week average of $67.86. Long-term investors watch that line because strong companies rarely trade below it for long.

How fast is Kyntra Bio, Inc. growing?

Over the last five fiscal years Kyntra Bio, Inc.'s revenue grew -48.4% a year; over ten years revenue grew -28.4% a year.

Does KYNB pay a dividend?

Kyntra Bio, Inc. does not currently pay a regular dividend.

Cite this page

Funkfolio, “Kyntra Bio, Inc. (KYNB) stock: price, valuation and fundamentals”, data as of 18 November 2026. https://funkfolio.com/stock/KYNB

Underlying data: Yahoo Finance; company filings with the SEC.